Acadia Healthcare stock analysis
Acadia Healthcare (7RA) Stock Price & Analysis
7RA Stock Chart & Stats
- Day’s Range
- EUR 33.80 - EUR 34.20
- 52-Week Range
- EUR 9.65 - EUR 35.00
- Previous Close
- EUR 34.40
- Volume
- N/A
- Average Volume (3M)
- 31
- Market Cap
- EUR 3.19B
- Enterprise Value
- EUR 5.09B
- Total Cash (Recent Filing)
- EUR 163.31M
- Total Debt (Recent Filing)
- EUR 2.50B
- Price to Earnings (P/E)
- ―
- Beta
- 0.04
- Next Earnings
- Mar 01, 2027 (Est.)
- EPS Estimate
- 0.35
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Raised Earnings Outlook
Repeated guidance increases indicate improving management confidence in the operating plan and earnings trajectory. The outlook combines higher revenue, EBITDA, adjusted EPS, and operating cash flow expectations, providing a durable foundation for execution over the next several quarters.
Capacity Expansion And Demand
New beds and facilities expand Acadia’s treatment capacity in a market where management reports strong behavioral healthcare demand. Rising acute volumes and revenue suggest the network is converting added capacity into growth, with further operating leverage possible as newer sites mature.
Improving Cash Generation
Positive free cash flow alongside debt repayment strengthens internal funding capacity and reduces reliance on external capital. If sustained, improving cash conversion can support facility investment, help manage leverage, and provide greater flexibility for strategic growth initiatives.
Bears Say
Severe Profitability Pressure
The sharp deterioration in net and gross margins indicates that revenue growth is not currently translating into comparable earnings strength. Persistent cost, pricing, or service-mix pressure could constrain reinvestment and make reported profitability volatile even as sales expand.
Elevated Leverage
Higher leverage combined with negative returns reduces financial flexibility and increases the importance of consistent cash generation. Debt obligations may limit capital allocation choices, while weak profitability makes balance-sheet improvement more dependent on operational recovery.
Ongoing Legal Investigation Costs
Material investigation-related spending remains a continuing drag on reported results and introduces uncertainty into future expenses. Even with year-over-year improvement, variable legal costs can absorb cash, complicate earnings forecasting, and distract management from operating priorities.
Acadia Healthcare News
7RA FAQ
What was Acadia Healthcare’s price range in the past 12 months?
What is Acadia Healthcare’s market cap?
When is Acadia Healthcare’s upcoming earnings report date?
How were Acadia Healthcare’s earnings last quarter?
Is Acadia Healthcare overvalued?
Does Acadia Healthcare pay dividends?
What is Acadia Healthcare’s EPS estimate?
How many shares outstanding does Acadia Healthcare have?
What happened to Acadia Healthcare’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Acadia Healthcare?
What is the TipRanks Smart Score and how is it calculated?
Acadia Healthcare Stock Smart Score
Company Description
Acadia Healthcare
Acadia Healthcare Company, Inc. specializes in delivering a comprehensive range of behavioral health services, with its operations spanning the United States and Puerto Rico. Patients receive care in diverse environments, including acute inpatient psychiatric hospitals, specialized treatment facilities, long-term residential centers, and outpatient clinics. As of March 31, 2022, the company managed an extensive network consisting of 238 behavioral healthcare facilities, collectively providing approximately 10,600 beds. Established in 2005, Acadia Healthcare is headquartered in Franklin, Tennessee.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Debra K. Osteen
- Employees
- 22,000
- Website
- www.acadiahealthcare.com
- Address
- 4020 Aspen Grove Drive, Franklin, TN, 37067, US
Acadia Healthcare (7RA) Earnings & Revenues
7RA Company Deck
7RA Earnings Call
Earnings Call SentimentPositive
The call was strongly positive. Acadia reported revenue, adjusted EBITDA, and adjusted EPS above expectations, generated $47 million of free cash flow, reduced debt by $63 million, raised full-year guidance for the third consecutive quarter, opened significant new capacity, and reported strong acute demand and improving CTC admissions. The main challenges were the New York Medicaid headwind, ongoing startup facility losses, flat sequential CTC revenue, lower commercial mix, shorter length of stay, and continued legal and revenue-cycle costs, but management described progress on each operational area and maintained a favorable outlook for 2027.
View all DE:7RA earnings summaries7RA Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 1 | 6 |
| Technical Analysis | 3 | 1 | 6 |
| Moving Averages | 12 | 0 | 0 |











